All In MedTech

Device Trial Radar · NCT05553158

Study to Investigate the Influence of Compression Treatment in Patients With Pelvic Congestion Syndrome (PCS)

Last checked: Nov 20, 2026Latest source record: Sep 23, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

172

Planned (sponsor's estimate)

Start

Nov 1, 2022

Primary completion

Nov 2024

Study completion Nov 2024

Sponsor

Lead sponsor
The Whiteley ClinicAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Bauerfeind
First posted
Sep 23, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
Female only, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Pelvic vein embolization (PVE) is the current treatment procedure used to treat women with Pelvic Congestion Syndrome (PCS). This treatment is not widely available, and many women when diagnosed with PCS cannot afford treatment. The purpose of this study is to assess whether compression therapy is an effective alternative treatment to PVE for women who are unwilling or unable to undergo treatment by PVE. Compression therapy would provide a cost-effective alternative to coil embolization.

Conditions

  • Pelvic Congestive Syndrome

Interventions

  • Compression pantsDevice

    Similar to compression stockings for the legs which are designed to apply pressure to improve venous return in the legs, compression pants have been designed to apply pressure to pelvic veins to improve the symptoms of Pelvic Congestion Syndrome.

  • Embolization coilsDevice

    Embolization coils are used to block the veins they are positioned in. This is a standard treatment offered to patients at The Whiteley Clinic.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change from Baseline in Quality of Life and Symptoms at one month post-treatment and at two months post-treatmentTime frame: Baseline (start of month 0), 1 month post-treatment (end of Month 2) and two months post-treatment (end of month 3)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Whiteley Clinic

    Guildford, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.